Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use BONJESTA safely and effectively. See full prescribing information for BONJESTA. BONJESTA (doxylamine succinate and pyridoxine hydrochloride), extended-release tablets, for oral use. Initial U.S. Approval: 1976
Medication labelWhy this: Advisory · dailymed-prescription
BONJESTA is indicated for the treatment of nausea and vomiting of pregnancy in women who do not respond to conservative management. Limitations of Use BONJESTA has not been studied in women with hyperemesis gravidarum.
- generic_name
- doxylamine succinate and pyridoxine hydrochloride
- product_names
- doxylamine succinate and pyridoxine hydrochloride
- ndc
- 55494-120, 55494-120-60, 55494-120-10, 55494-120-99, 55494-120-94
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en